Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Funds / Alpha Ascent Organelle LLC

Alpha Ascent Organelle LLC

Active deploymentClosed to new capitalFundADV: Venture Capital FundAlpha Ascent Ventures LLCDelaware
Amounts, each with its basis
Vintage
2022basis: form d first sale
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
$2.0Mwhat may be sold, not what was raised; file 021-467561, sworn by the adviser or filed under this vehicle
Form D sold
$2.0Mas of the filing of Dec 15, 2022, 17 investors
First sale
Dec 13, 2022
Reported GAV
$2.0Mon the Form ADV filed Sep 12, 2026; the fund's assets, never its size or dry powder
Owners (ADV)
17
Reported on ADV
Sep 12, 2026 to Sep 12, 2026
Fundraising evidence
Closed to new capital
Form D filed or amended 2022-12-15: the stated $2.0M offering reported fully sold (fr-1)
evidence dated Dec 15, 2022. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Active deployment
vintage 2 to 4 years
age years: 4first sale: 2022-12-13vintage year: $2,022adv gav as of: 2026-09-12vintage basis: form_d_first_saleform d sold usd: $2.0Mform d offering usd: $2.0Mform d latest filed at: 2022-12-15
The fund's own reporting through time
1 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Sep 12, 2026Venture Capital Fund$2.0M
17$25,0004%
Principals and agents
5 principals on Form D, 2 placement agents
  • Arthur Maloy Director
  • Alpha Ascent Ventures LLC Promoter
  • Eric Greenberg Director
  • Alpha Ascent Organelle Manager LLC Promoter
  • Alpha Ascent Organelle Manager LLC general partner (ADV 7.B.(1).A.3)
  • Ascent Capital Advisors Limited placement agent
  • BCW Securities LLC placement agent
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
2 events
  1. Sep 12, 2026
    Alpha Ascent Organelle LLC first reported on Form ADV by Alpha Ascent Ventures LLC, GAV $1,999,985
    Fund first reported on Form ADV Fact IAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
  2. Dec 15, 2022
    Alpha Ascent Organelle LLC filed Form D: $2,000,000 sold of $2,000,000, Venture Capital Fund
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
17 observations
Every observation on this vehicle